New care model aims to save mothers and babies with sickle cell disease

NCT ID NCT05143021

Ongoing Disease control Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special care program for pregnant women with sickle cell disease in Ghana. A team of obstetric and sickle cell experts works together to prevent complications and reduce deaths. Researchers will track 500 women to see if this low-cost approach improves survival and health for both mothers and babies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Multidisciplinary care program (obstetrics and sickle cell disease teams)
What this could lead to: If successful, this could provide a low-cost model to reduce maternal and infant deaths in sickle cell disease pregnancies.
What could go wrong: This is an observational study without a control group, so improvements may be due to other factors. Results may not apply outside Ghana.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY RELATED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pregnancy disorder sickle cell disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREGNANCY RELATED SICKLE CELL DISEASE

Contacts and locations

Locations

Greater Accra Regional Hospital

Accra, Ghana
Korle Bu Teaching Hospital

Accra, Ghana
Tamale Teaching Hospital

Tamale, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.